William Callahan
Director/Board Member at MEDISUN PRECISION MEDICINE LTD.
William Callahan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MEDISUN PRECISION MEDICINE LTD. | Director/Board Member | 2015-06-30 | - |
| Independent Dir/Board Member | 2015-06-30 | - |
Career history of William Callahan
Former positions of William Callahan
| Companies | Position | Start | End |
|---|---|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Chief Operating Officer | 2009-11-18 | 2012-01-31 |
| TALPHERA, INC. | Corporate Officer/Principal | 2014-02-28 | - |
Training of William Callahan
| San Francisco State University | Undergraduate Degree |
Statistics
International
| United States | 4 |
Operational
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TALPHERA, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Medisun Precision Medicine Ltd.
 Medisun Precision Medicine Ltd. BiotechnologyHealth Technology Medisun Precision Medicine Ltd. is a biotechnology company, which focuses on developing novel neurological therapies to be directly delivered into specific regions of the brain. It portfolio includes ACX-31 program to deliver two chemotherapy drugs, temozolomide in combination with BCNU, locally to brain tumor sites. The company was founded on August 29, 2012 and is headquartered in Majuro, Marshall Islands. | Health Technology |
- Stock Market
- Insiders
- William Callahan
- Experience
